UnitedHealth Group (NYSE:UNH) Posts Earnings Results, Misses Expectations By $0.09 EPS

UnitedHealth Group (NYSE:UNH - Get Free Report) posted its quarterly earnings data on Thursday. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09), RTT News reports. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business earned $6.91 EPS. UnitedHealth Group updated its FY 2025 guidance to 26.000-26.500 EPS.

UnitedHealth Group Stock Performance

UNH stock traded down $128.94 during trading on Friday, reaching $456.10. 29,048,929 shares of the company's stock were exchanged, compared to its average volume of 4,373,443. UnitedHealth Group has a 1-year low of $438.50 and a 1-year high of $630.73. The company's fifty day moving average price is $512.95 and its 200-day moving average price is $540.65. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $417.20 billion, a PE ratio of 29.43, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on UNH shares. Truist Financial upped their target price on UnitedHealth Group from $610.00 to $660.00 and gave the company a "buy" rating in a research note on Friday, April 11th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, KeyCorp reiterated an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $632.85.

Institutional Investors Weigh In On UnitedHealth Group

A hedge fund recently raised its stake in UnitedHealth Group stock. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 137.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,019 shares of the healthcare conglomerate's stock after purchasing an additional 2,324 shares during the period. Revolve Wealth Partners LLC's holdings in UnitedHealth Group were worth $2,033,000 as of its most recent SEC filing. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.